<VariationArchive VariationID="654006" VariationName="NM_033305.3(VPS13A):c.3556_3557dup (p.Val1187fs)" VariationType="Duplication" Accession="VCV000654006" Version="12" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-02-28" DateCreated="2019-08-14" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="638388" VariationID="654006">
      <GeneList>
        <Gene Symbol="VPS13A" FullName="vacuolar protein sorting 13 homolog A" GeneID="23230" HGNC_ID="HGNC:1908" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="77177534" stop="77421537" display_start="77177534" display_stop="77421537" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="79792360" stop="80032398" display_start="79792360" display_stop="80032398" Strand="+" />
          </Location>
          <OMIM>605978</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_033305.3(VPS13A):c.3556_3557dup (p.Val1187fs)</Name>
      <CanonicalSPDI>NC_000009.12:77295589:AC:ACAC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="77295589" stop="77295590" display_start="77295589" display_stop="77295590" variantLength="2" positionVCF="77295589" referenceAlleleVCF="A" alternateAlleleVCF="AAC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="79910505" stop="79910506" display_start="79910505" display_stop="79910506" variantLength="2" positionVCF="79910505" referenceAlleleVCF="A" alternateAlleleVCF="AAC" />
      </Location>
      <ProteinChange>V1187fs</ProteinChange>
      <ProteinChange>V1148fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033305.2" sequenceAccession="NM_033305" sequenceVersion="2" change="c.3556_3557dupAC">
            <Expression>NM_033305.2:c.3556_3557dupAC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033305.3" sequenceAccession="NM_033305" sequenceVersion="3" change="c.3556_3557dupAC" MANESelect="true">
            <Expression>NM_033305.3:c.3556_3557dupAC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008931.1" sequenceAccession="NG_008931" sequenceVersion="1" change="g.123146_123147dup">
            <Expression>NG_008931.1:g.123146_123147dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018037.2" sequenceAccession="NM_001018037" sequenceVersion="2" change="c.3439_3440dup">
            <Expression>NM_001018037.2:c.3439_3440dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018047.1" sequenceAccession="NP_001018047" sequenceVersion="1" change="p.Val1148fs">
            <Expression>NP_001018047.1:p.Val1148fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018038.3" sequenceAccession="NM_001018038" sequenceVersion="3" change="c.3556_3557dup">
            <Expression>NM_001018038.3:c.3556_3557dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018048.1" sequenceAccession="NP_001018048" sequenceVersion="1" change="p.Val1187fs">
            <Expression>NP_001018048.1:p.Val1187fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015186.4" sequenceAccession="NM_015186" sequenceVersion="4" change="c.3556_3557dup">
            <Expression>NM_015186.4:c.3556_3557dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056001.1" sequenceAccession="NP_056001" sequenceVersion="1" change="p.Val1187fs">
            <Expression>NP_056001.1:p.Val1187fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033305.3" sequenceAccession="NM_033305" sequenceVersion="3" change="c.3556_3557dup" MANESelect="true">
            <Expression>NM_033305.3:c.3556_3557dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_150648.2" sequenceAccession="NP_150648" sequenceVersion="2" change="p.Val1187fs">
            <Expression>NP_150648.2:p.Val1187fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.79910506_79910507dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.79910506_79910507dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.77295590_77295591dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.77295590_77295591dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="605978.0009" DB="OMIM" />
        <XRef Type="rs" ID="779746050" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00008" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00022" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033305.3(VPS13A):c.3556_3557dup (p.Val1187fs) AND not provided" Accession="RCV000809886" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-19" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033305.3(VPS13A):c.3556_3557dup (p.Val1187fs) AND Chorea-acanthocytosis" Accession="RCV001276369" Version="4">
        <ClassifiedConditionList TraitSetID="1286">
          <ClassifiedCondition DB="MedGen" ID="C0393576">Chorea-acanthocytosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-19" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-19" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2019-08-14" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11381253</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12404112</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17998451</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21598378</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22038564</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1286" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="805" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Choreaacanthocytosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acanthocytosis with neurologic disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levine-Critchley syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Chorea-acanthocytosis</ElementValue>
                <XRef ID="MONDO:0008695" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Choreoacanthocytosis</ElementValue>
                <XRef ID="Choreoacanthocytosis/1384" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CHAC</ElementValue>
                <XRef ID="GTR000501217" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="200150" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Chorea-acanthocytosis (ChAc) is characterized by a progressive movement disorder, cognitive and behavior changes, a myopathy that can be subclinical, and chronic hyperCKemia in serum. Although the disorder is named for acanthocytosis of the red blood cells, this feature is variable. The movement disorder is mostly limb chorea, but some individuals present with parkinsonism. Dystonia is common and affects the oral region and especially the tongue, causing dysarthria and serious dysphagia with resultant weight loss. Habitual tongue and lip biting are characteristic, as well as tongue protrusion dystonia. Progressive cognitive and behavioral changes resemble those in a frontal lobe syndrome. Seizures are observed in almost half of affected individuals and can be the initial manifestation. Myopathy results in progressive distal muscle wasting and weakness. Mean age of onset in ChAc is about 30 years, although ChAc can develop as early as the first decade or as late as the seventh decade. It runs a chronic progressive course and may lead to major disability within a few years. Life expectancy is reduced, with age of death ranging from 28 to 61 years.</Attribute>
                <XRef ID="NBK1387" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3956" />
                <XRef ID="3956" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301561</ID>
                <ID Source="BookShelf">NBK1387</ID>
              </Citation>
              <XRef ID="2388" DB="Orphanet" />
              <XRef ID="C0393576" DB="MedGen" />
              <XRef ID="MONDO:0008695" DB="MONDO" />
              <XRef Type="MIM" ID="200150" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2877856" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_033305.3:c.3556_3557dupAC|Choreaacanthocytosis" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001462581" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033305.3:c.3556_3557dupAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Choreaacanthocytosis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="25130" SubmissionDate="2019-12-18" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="605978.0009_CHOREOACANTHOCYTOSIS" title="VPS13A, 2-BP DUP, 3556AC_CHOREOACANTHOCYTOSIS" />
        <ClinVarAccession Accession="SCV000025130" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 Mexican mestizo sisters, born of consanguineous parents, with choreoacanthocytosis (CHAC; 200150), Ruiz-Sandoval et al. (2007) identified a homozygous 2-bp duplication (3556dupAC) in exon 33 of the VPS13A gene, resulting in a frameshift and premature termination. The proband had onset at age 32 years and showed severe progression of the disorder; at age 42, she was emaciated, anarthric, and reactive only to simple commands. In contrast, her sister had onset at age 45 years and primarily showed motor and verbal tics, paranoid behavior, and depression.</Attribute>
              <Citation>
                <ID Source="PubMed">17998451</ID>
              </Citation>
              <XRef DB="OMIM" ID="200150" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VPS13A" />
          </GeneList>
          <Name>VPS13A, 2-BP DUP, 3556AC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DUP, 3556AC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605978.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CHOREOACANTHOCYTOSIS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3674630" SubmissionDate="2022-04-27" DateLastUpdated="2023-03-04" DateCreated="2021-09-19">
        <ClinVarSubmissionID localKey="GDXSV:225311" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001873735" DateUpdated="2023-03-04" DateCreated="2021-09-19" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Not observed at a significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 17998451, 11381253, 9382101, 22038564)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VPS13A" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:658071</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033305.2:c.3556_3557dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_103_20220427054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_39_20210915114944</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7523250" SubmissionDate="2023-07-25" DateLastUpdated="2023-07-29" DateCreated="2023-07-29">
        <ClinVarSubmissionID localKey="NM_033305.2:c.3556_3557dupAC|MedGen:C0393576" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004021263" DateUpdated="2023-07-29" DateCreated="2023-07-29" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22038564</ID>
          </Citation>
          <Comment>Variant summary: VPS13A c.3556_3557dupAC (p.Val1187LeufsX12) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 2.4e-05 in 250632 control chromosomes (gnomAD). c.3556_3557dupAC has been reported in the literature in individuals affected with Choreoacanthocytosis (e.g. Walker_2012), and at least one was reported as compound heterozygous with another pathogenic variant. These data suggest the variant is likely to be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 22038564). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and classified it as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VPS13A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033305.2:c.3556_3557dupAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0393576" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13707883</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1844157" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="162413|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000950067" DateUpdated="2024-02-20" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12404112</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21598378</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11381253</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17998451</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val1187Leufs*12) in the VPS13A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13A are known to be pathogenic (PMID: 12404112, 21598378). This variant is present in population databases (rs779746050, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with chorea-acanthocytosis (PMID: 11381253, 17998451). ClinVar contains an entry for this variant (Variation ID: 654006). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VPS13A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.79910505_79910506insAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1844157" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2877856" TraitType="Disease" MappingType="Name" MappingValue="Choreaacanthocytosis" MappingRef="Preferred">
        <MedGen CUI="C0393576" Name="Chorea-acanthocytosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7523250" TraitType="Disease" MappingType="XRef" MappingValue="C0393576" MappingRef="MedGen">
        <MedGen CUI="C0393576" Name="Chorea-acanthocytosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25130" TraitType="Disease" MappingType="Name" MappingValue="CHOREOACANTHOCYTOSIS" MappingRef="Preferred">
        <MedGen CUI="C0393576" Name="Chorea-acanthocytosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3674630" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

